These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37504249)

  • 41. Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairs.
    Jeoung MH; Kim TK; Shim H; Lee S
    J Immunol Methods; 2016 Sep; 436():22-8. PubMed ID: 27288967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells.
    Erb U; Megaptche AP; Gu X; Büchler MW; Zöller M
    J Hematol Oncol; 2014 Mar; 7():29. PubMed ID: 24684724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
    Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
    Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CD44 splice variants in human skin and epidermal tumours.
    Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
    Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.
    Martegani MP; Del Prete F; Gasbarri A; Natali PG; Bartolazzi A
    Am J Pathol; 1999 Jan; 154(1):291-300. PubMed ID: 9916943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
    Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
    J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
    Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y
    Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.
    Van Hal NL; Van Dongen GA; Rood-Knippels EM; Van Der Valk P; Snow GB; Brakenhoff RH
    Int J Cancer; 1996 Nov; 68(4):520-7. PubMed ID: 8945625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
    Ashida K; Terada T; Kitamura Y; Kaibara N
    Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
    Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
    Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia.
    Hale LP; Patel DD; Clark RE; Haynes BF
    J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
    Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
    Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD44 in normal human pancreas and pancreatic carcinoma cell lines.
    Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M
    Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Definition of the specificity of monoclonal antibodies against porcine CD45 and CD45R: report from the CD45/CD45R and CD44 subgroup of the Second International Swine CD Workshop.
    Zuckermann FA; Peavey C; Schnitzlein WM; Schabacker D; Husmann RJ; Yang H; Saalmüller A; Lunney JK
    Vet Immunol Immunopathol; 1998 Jan; 60(3-4):367-87. PubMed ID: 9589574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.